Development and validation of the predictive aplastic score system (PASS): a simplified tool to diagnose acquired aplastic anemia in adults.

Saved in:
Bibliographic Details
Title: Development and validation of the predictive aplastic score system (PASS): a simplified tool to diagnose acquired aplastic anemia in adults.
Authors: Aleixo G; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Cheon H; Internal Medicine Residency Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zheng J; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Soewito S; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee J; Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA., Kaphan E; APHP, Service D'hématologie Greffe, Hôpital Saint-Louis, Paris, France., Kalakuntla N; School of Medicine, UT Southwestern Medical Center, Dallas, TX, USA., Jen WY; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kotha S; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rupsee A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Djulbegovic M; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Matthews JA; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia TM; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Olson TS; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Comprehensive Bone Marrow Failure Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Peffault de Latour R; APHP, Service D'hématologie Greffe, Hôpital Saint-Louis, Paris, France.; French Reference Center for AA & PNH, Inserm U1342, Saint Louis Research Institute, Team Translational Immunology in Immunotherapy and Hematology, Leukemia Institute Paris Saint Louis, Université Paris Cité, Paris, France., Sicre De Fontbrune F; APHP, Service D'hématologie Greffe, Hôpital Saint-Louis, Paris, France., Bat T; Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA., DiNardo CD; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Babushok DV; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. daria.babushok@pennmedicine.upenn.edu.; Comprehensive Bone Marrow Failure Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. daria.babushok@pennmedicine.upenn.edu.
Source: Leukemia [Leukemia] 2026 Apr 27. Date of Electronic Publication: 2026 Apr 27.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-026-02924-3